Physician profile
Andrew Christopher Miller
NPI 1598707671
$127,884.81
in general payments reported to CMS, 2019-2025
6 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $10K · 2021: $2,592 · 2022: $9,383 · 2023: $17K · 2024: $31K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Consulting Fee: $7,470 · Travel and Lodging: $5,738 · Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,913.00 |
| Consulting Fee | $7,470.00 |
| Travel and Lodging | $5,738.41 |
| Food and Beverage | $413.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $90,034.26 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $26,960.59 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $10,710.75 | 2022-2024 | Xarelto |
| Portola Pharmaceuticals, LLC | $124.80 | 2019 | |
| Galderma Laboratories, L.P. | $37.14 | 2024 | |
| Stryker Corporation | $17.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.